Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence... see more

CSE:IME - Post Discussion

Imagin Medical Inc > TOTAL SMELLY JOB!! STINKS HERE!
View:
Post by Predator2018 on Oct 29, 2020 7:36pm

TOTAL SMELLY JOB!! STINKS HERE!

Dilute it hard to feed the BEAST then consolidate and repeat the SMELLY JOB again and again. Legit as long as you have gullible Suckers and filing your pumping news and meeting regulatory filings requirements. SPEND the money on related entities for consulting fees, administration and BLAH BLAH BLAH!! Happens a lot in the penny stock world. In few years, they will dilute the story to near 200 million shares and repeat the game again. Always looking for new SUCKERS!! AVOID BAD STOCKS!!
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities